Delivery Order SPE2DR25D1200-SPE2DR26FMK6M
- Not listed
- The Defense Logistics Agency awarded a $1,838.49 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Adderall 10 mg tablets in quantities of 100. This firm fixed-price delivery order, with an ultimate completion date of December 9, 2025, represents a non-competitive set-aside contract issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Adderall 15 mg tablets (100 count) with a ceiling value of $5,233.57. This firm fixed-price delivery order, with an ultimate completion date of September 11, 2025, represents a single pharmaceutical supply transaction under AmerisourceBergen's existing contract vehicle with DLA. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. No...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Adderall 15 mg tablets in quantities of 100 units, with a ceiling value of $11,296.62. This competitively awarded, firm fixed-price delivery order is set to be completed by August 5, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction within AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Adderall 5 mg tablets in quantities of 100 units. This competitive, firm fixed-price delivery order carries a ceiling value of $6,128.30 and is scheduled for completion by January 16, 2026. The contract has no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 15 mg tablets (100-count units) under a firm fixed-price contract valued at $8,773.53, with an ultimate completion date of December 15, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026....
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corp a delivery order valued at $3,676.98 for Adderall 30mg tablets (100 count) on January 20, 2026, with an ultimate completion date of January 21, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (which operates under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Adderall 15 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $2,532.04 and a completion deadline of June 20, 2025. The award was competitively procured with no set-aside designation, and the product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $12,063.51 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Adderall 10 mg tablets (100-count units), with an ultimate completion date of December 8, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,930.88 to AmerisourceBergen Drug Corp for the supply of Adderall tablets (30mg) on January 12, 2026, with an ultimate completion date of January 13, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Adderall 10 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $9,850.72 with a firm fixed price structure and an ultimate completion date of January 6, 2026. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D1200Indefinite Delivery Contract
- SPE2DR25D1200-SPE2DR26FMK6MDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 15 mg tablets (100-count units) on January 22, 2026, with a ceiling value of $1,074.15 and ultimate completion date of January 23, 2026. This competitively awarded, non-set-aside contract represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2031. The pharmaceutical supply will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting the company's role as a critical vendor for federal military healthcare procurement. This delivery order exemplifies the operational scope of Cencora's comprehensive IDC vehicle, which enables efficient fulfillment of pharmaceutical and medical supply requirements across military treatment facilities and federal healthcare systems worldwide. The firm fixed-price delivery order structure reflects the standardized procurement approach used by DLA for routine pharmaceutical acquisitions from its established prime vendors. AmerisourceBergen's position as a major pharmaceutical distributor allows it to supply diverse therapeutic products, including controlled substances and specialty medications, supporting the Defense Health Agency and broader military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/21/26 |